Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 2/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.50 |
| ▸ | AR | P10275 | 6/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.50 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10847397 | 0.84 | MEN1 (0.54) | CA9CA12CA1MAOACYP3A4 | |
| SCHEMBL10848826 | 0.82 | AR (0.50) | CA9CA12CA1MAOACYP3A4 | |
| SCHEMBL8114895 | 0.82 | CA9 (0.55) | CA9CA12CA1MAOACYP3A4 | |
| SCHEMBL4930754 | 0.82 | ALDH1A1 (0.64) | CA9CA12CA1MAOACYP3A4 | |
| SCHEMBL5346812 | 0.82 | ALDH1A1 (0.59) | CA9CA12CA1CYP3A4KMT2A | |
| SCHEMBL10794104 | 0.82 | CA12 (0.50) | CA9CA12CA1MAOACYP3A4 | |
| SCHEMBL3910257 | 0.82 | CA9 (0.55) | CA9CA12CA1MAOACYP3A4 | |
| SCHEMBL5342252 | 0.82 | CA9 (0.55) | CA9CA12CA1CYP3A4AR | |
| SCHEMBL8117166 | 0.82 | CA9 (0.55) | CA9CA12CA1MAOACYP3A4 | |
| SCHEMBL9160367 | 0.80 | ALDH1A1 (0.64) | CA9CA12CA1MAOAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4317284-A1 | COMPOSITION FOR FLUORINE RUBBER CROSSLINKING AND MOLDED ARTICLE | Daikin Industries, Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-20240034856-A1 | COMPOSITION FOR FLUORINE RUBBER CROSSLINKING AND MOLDED ARTICLE | DAIKIN INDUSTRIES, LTD. (JP) | 2024-02-01 | — | — | US | disclosed |
| CN-117043260-A | Composition for cross-linking fluororubber and molded article | 大金工业株式会社 | 2023-11-10 | — | — | CN | disclosed |
| WO-2022210044-A1 | COMPOSITION FOR FLUORINE RUBBER CROSSLINKING AND MOLDED ARTICLE | ダイキン工業株式会社 | 2022-10-06 | — | — | WO | disclosed |
| EP-3848367-A1 | TRICYCLIC COMPOUNDS ACTING ON CRBN PROTEINS | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2021-07-14 | — | — | EP | disclosed |
| US-7384975-B2 | Substituted furochromenes, preparation thereof and their antiinflammatory action | GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) | 2008-06-10 | — | — | US | disclosed |
| US-7208518-B2 | Substituted furochromene compounds of antiinflammatory action | GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) | 2007-04-24 | — | — | US | disclosed |
| CN-1839138-A | Substituted furochromene compounds with anti-inflammatory action | PLIVA ISTRAZIVACKI INST D O O (HR) | 2006-09-27 | — | — | CN | disclosed |
| CN-1839137-A | Substituted furochromenes, preparation thereof and their antiinflammatory action | PLIVA ISTRAZIVACKI INST D O O (HR) | 2006-09-27 | — | — | CN | disclosed |
| US-20060148890-A1 | Substituted furochromene compounds of antiinflammatory action | PLIVA-LSTRAZIVACKI INSTITUT D.O.O. (HR) | 2006-07-06 | — | — | US | disclosed |
| EP-0968202-B1 | Process for preparing photoactive coumarin dervatives | CLARIANT FINANCE BVI LTD (VG) | 2002-07-03 | — | — | EP | disclosed |
| EP-0977747-B1 | PHOTOACTIVE COUMARIN DERIVATIVES | CLARIANT FINANCE BVI LTD (VG) | 2002-06-12 | — | — | EP | disclosed |
| US-6114546-A | Aminomethylene derivatives and ultraviolet absorbent comprising thereof | CHEMIPRO KASEI KAISHA, LIMITED (JP) | 2000-09-05 | — | — | US | disclosed |
| CN-1254338-A | Process for preparing photoactive coumarin derivatives | HOECHST CELANESE CORP (CH) | 2000-05-24 | — | — | CN | disclosed |
| EP-0977747-A1 | PHOTOACTIVE COUMARIN DERIVATIVES | CLARIANT INTERNATIONAL LTD. (CH) | 2000-02-09 | — | — | EP | disclosed |
| EP-0968202-A1 | PROCESS FOR PREPARING PHOTOACTIVE COUMARIN DERIVATIVES | CLARIANT INTERNATIONAL LTD. (CH) | 2000-01-05 | — | — | EP | disclosed |
| EP-0950655-A1 | AMINOMETHYLENE DERIVATIVES AND ULTRAVIOLET ABSORBER COMPRISING THE SAME | CHEMIPRO KASEI KAISHA, LIMITED (JP) | 1999-10-20 | — | — | EP | disclosed |
| WO-1998039317-A1 | PROCESS FOR PREPARING PHOTOACTIVE COUMARIN DERIVATIVES | CLARIANT INTERNATIONAL LTD. (CH) | 1998-09-11 | — | — | WO | disclosed |
| WO-1998039319-A1 | PHOTOACTIVE COUMARIN DERIVATIVES | CLARIANT INTERNATIONAL LTD. (CH) | 1998-09-11 | — | — | WO | disclosed |
| WO-1993003036-A1 | BENZOPYRANO[4,3-c]PYRAZOLES, THEIR PREPARATION AND THEIR USE AS IMMUNOMODULATORS | THE BOOTS COMPANY PLC (GB) | 1993-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060148890-A1 | Substituted furochromene compounds of antiinflammatory action | LTC4S, CYP11B2, CYP11B1 | CA9 2752/4885CA12 3303/4885CA1 1868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.